The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104630482 10463048 2 F 20160926 20140919 20160929 EXP US-ROCHE-1459853 ROCHE VERNA E, SAXENA V, BURTON J, OLEARY J, DODGE J, STRAVITZ R, LEVITSKY J, TROTTER J, EVERSON G, BROWN R AND TERRAULT N. TELAPREVIR- AND BOCEPREVIR-BASED TRIPLE THERAPY FOR HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS WITH ADVANCED RECURRENT DISEASE: A MULTICENTER STUDY. TRANSPLANTATION 2015;99 (8):1644-1651. 0.00 Y 0.00000 20160929 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104630482 10463048 1 PS Peg-Interferon Alfa 2a PEGINTERFERON ALFA-2A 1 Unknown D 103964 180 UG /wk
104630482 10463048 2 SS RIBAVIRIN. RIBAVIRIN 1 Unknown D 21511
104630482 10463048 3 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 Unknown D 50722
104630482 10463048 4 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 D 50722
104630482 10463048 5 SS PEGINTERFERON ALFA-2B PEGINTERFERON ALFA-2B 1 Unknown D 0 1.5 UG/KG /wk
104630482 10463048 6 SS CONSENSUS INTERFERON INTERFERON ALFACON-1 1 Unknown D 0
104630482 10463048 7 SS BOCEPREVIR BOCEPREVIR 1 Unknown D 0 800 MG TID
104630482 10463048 8 SS TELAPREVIR TELAPREVIR 1 Unknown D 0 750 MG TID
104630482 10463048 9 SS TELAPREVIR TELAPREVIR 1 Unknown D 0 1125 MG BID
104630482 10463048 10 SS CYCLOSPORINE. CYCLOSPORINE 1 Unknown D 0
104630482 10463048 11 SS CYCLOSPORINE. CYCLOSPORINE 1 D 0
104630482 10463048 12 SS TACROLIMUS. TACROLIMUS 1 Unknown D 0
104630482 10463048 13 SS TACROLIMUS. TACROLIMUS 1 D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104630482 10463048 1 Hepatitis C
104630482 10463048 2 Hepatitis C
104630482 10463048 3 Liver transplant
104630482 10463048 4 Renal transplant
104630482 10463048 5 Hepatitis C
104630482 10463048 6 Hepatitis C
104630482 10463048 7 Hepatitis C
104630482 10463048 8 Hepatitis C
104630482 10463048 10 Liver transplant
104630482 10463048 11 Renal transplant
104630482 10463048 12 Renal transplant
104630482 10463048 13 Liver transplant

Outcome of event

Event ID CASEID OUTC COD
104630482 10463048 HO
104630482 10463048 OT
104630482 10463048 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
104630482 10463048 Acute kidney injury
104630482 10463048 Anaemia
104630482 10463048 Ascites
104630482 10463048 Bacteraemia
104630482 10463048 Hepatic cirrhosis
104630482 10463048 Hepatic failure
104630482 10463048 Infection
104630482 10463048 Leukopenia
104630482 10463048 Rash
104630482 10463048 Renal failure
104630482 10463048 Thrombocytopenia
104630482 10463048 Transplant rejection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found